Morgan Stanley
BGMD

Morgan Stanley’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

Morgan Stanley’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-28
Closed – – 6934
2015
Q2 		$0 Hold
28
– – ﹤0.01% 6929
2015
Q1 		$0 Hold
28
– – ﹤0.01% 6833
2014
Q4 		$0 Hold
28
– – ﹤0.01% 6839
2014
Q3 		$0 Sell
28
-3,686
-99% -$12.3K ﹤0.01% 6799
2014
Q2 		$16K Sell
3,714
-4,279
-54% -$20.3K ﹤0.01% 6086
2014
Q1 		$62K Buy
7,993
+4,605
+136% +$25.4K ﹤0.01% 5636
2013
Q4 		$14K Sell
3,388
-1,950
-37% -$5.67K ﹤0.01% 5971
2013
Q3 		$20K Sell
5,338
-8,164
-60% -$34.4K ﹤0.01% 5281
2013
Q2 		$72K Buy
+13,502
New +$90K ﹤0.01% 5141

Other funds holding BGMD

AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Morgan Stanley's BGMD Position: Q3 2015 in Review

Morgan Stanley sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q3 2015, closing a stake of 28 shares.

Morgan Stanley first reported a position in BGMD in Q2 2013 and held it in 9 quarters. The position peaked at $72K in Q2 2013. 2 funds tracked by Wall St. Rank hold BGMD as of Q3 2015.

  • Morgan Stanley reported no remaining BG MEDICINE INC COM STK NEW position as of Q3 2015 after selling out during the quarter.
  • Morgan Stanley sold 28 BG MEDICINE INC COM STK NEW shares in Q3 2015.
  • Morgan Stanley first reported a position in BG MEDICINE INC COM STK NEW in Q2 2013 and held it in 9 quarters.
  • Morgan Stanley's BG MEDICINE INC COM STK NEW position peaked at $72K in Q2 2013.
  • 2 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2015.

Based on Morgan Stanley's 13F filing for Q3 2015, filed 9 Nov 2015.